Comparison the amoxicillin and pantoprazole regimen with quadruple regimen for Helicobacter pylori eradicatio
Phase 3
Recruiting
- Conditions
- Helicobacter pylori infection.Helicobacter pylori [H. pylori] as the cause of diseases classified elsewhereB96.81
- Registration Number
- IRCT20211019052812N1
- Lead Sponsor
- Ahvaz University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 166
Inclusion Criteria
Age more than 18 years
Confirm diagnosis of H. pylori infection by stool antigen test
No previous treatment of H. pylori infection
Patient consent to participate in the study
Exclusion Criteria
Use of antibiotics or nonsteroidal anti-inflammatory drugs (NSAIDs) in the last 4 weeks
allergy to any of the studied drugs
History of gastric surgery or the presence of a serious concomitant disease such as cancer,
Pregnant or lactating women
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Presence of Helicobacter pylori infection. Timepoint: Two weeks after the end of treatment. Method of measurement: Assess the presence of infection based on Stool Antigen Test.
- Secondary Outcome Measures
Name Time Method Treatment complication. Timepoint: Patients clinical visits every two weeks and fallow up by phone call every week. Method of measurement: Presence of nausea, vomiting and any allergic reactions based on clinical information.